Abstract
The binary GAL4-UAS system of conditional gene expression is widely used by Drosophila geneticists to target expression of the desired transgene in tissue of interest. In many studies, a preferred target tissue is the Drosophila eye, for which the sev-GAL4 and GMR-GAL4 drivers are most widely used since they are believed to be expressed exclusively in the developing eye cells. However, several reports have noted lethality following expression of certain transgenes under these GAL4 drivers notwithstanding the fact that eye is not essential for survival of the fly. Therefore, to explore the possibility that these drivers may also be active in tissues other than eye, we examined the expression of UAS-GFP reporter driven by the sev-GAL4 or GMR-GAL4 drivers. We found that both these drivers are indeed expressed in additional tissues, including a common set of specific neuronal cells in larval and pupal ventral and cerebral ganglia. Neither sev nor glass gene has so far been reported to be expressed in these neuronal cells. Expression pattern of sev-GAL4 driver parallels that of the endogenous Sevenless protein. In addition to cells in which sev-GAL4 is expressed, the GMR-GAL4 is expressed in several other larval cell types also. Further, two different GMR-GAL4 lines also show some specific differences in their expression domains outside the eye discs. These findings emphasize the need for a careful confirmation of the expression domains of a GAL4 driver being used in a given study, rather than relying only on the empirically claimed expression domains.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The binary GAL4-UAS system (Brand and Perrimon 1993) has greatly facilitated functional genomics through targeted expression of the desired transgene in a spatially and temporally regulated manner in Drosophila melanogaster. One of the great advantages of this system is that it permits ectopic expression of potentially harmful/toxic transgenes in specific tissues which are not essential for survival. Drosophila eye is one such organ which has been widely used as a model for studying genetic interaction between different genes, especially in relation to neurogenetic studies. The most widely used GAL4 drivers for targeting the UAS-carrying responder gene’s expression to developing eyes are the GMR-GAL4 and sevenless-GAL4transgenes. The GMR-GAL4 (Freeman 1996) driver is believed to be expressed from mid-third-instar stage through pupal development exclusively in all cells posterior to the morphogenetic furrow (MF) in differentiating larval eye discs (Freeman 1996). On the other hand, following the reported expression domain of the sevenless (sev) gene (Bowtell et al. 1991; Maxiner et al. 1998; Firth et al. 2006), the sev-GAL4 driver is believed to be expressed exclusively in the developing photoreceptor cells, initially in the nine Sevenless equivalence group cells in each ommatidial cluster (Tomlinson et al. 1987), which includes the precursors of the R1/R6, R3/R4, R7 photoreceptors and four cone cells, and finally only in the R7 photoreceptors. These two drivers have been used in a very large number of studies with the belief that expression of the target UAS-transgene would be driven only in the eye discs/eyes as noted above. However, several studies (Firth et al. 2006; Morris et al. 2006; Mallik and Lakhotia 2009a, ??b) have reported pupal lethality following GMR-GAL4 or sev-GAL4 driven expression of certain UAS-transgene constructs, notwithstanding the fact that even a complete absence of eyes has no effect on viability of pupae and emergence of adult flies (Sang and Jackson 2005). These observations raise the possibility that these two drivers activate expression of the target transgene in some other tissues also, which may actually be responsible for the observed lethality. Therefore, we examined sev-GAL4or GMR-GAL4driven expression of the UAS-GFP reporter transgene to identify the embryonic, larval and pupal tissues in which these drivers are active. Our results showed that, in addition to the above noted well-known expression domains of these two GAL4 drivers in developing eyes, each of them specifically activates the reporter gene in several other cells as well, including specific neuronal cells in larval and pupal brain and the ventral ganglia.
Materials and methods
Fly stocks
All flies stocks and crosses were maintained on standard agar cornmeal medium at 24 ± 1°C. The w 1118; sev-GAL4; + (no. 5793; Bailey 1999), w 1118; UAS-GFP; + (no. 1521), and w 1118; Ddc-GAL4; + (no. 7010), stocks were obtained from the Bloomington Stock Center (USA). Two GMR-GAL4 stocks, one with the GMR-GAL4 transgene (Freeman 1996) inserted on chromosome 2 (w 1118; GMR-GAL4; + ) and the other with the GMR-GAL4 transgene inserted on chromosome 3 (w 1118; + ; GMR-GAL4, Igaki et al. 2002) were used. These two transgene insertions are designated in the following as GMR-GAL4 2 and GMR-GAL4 3, respectively.
Reporter gene expression
The w 1118; GMR-GAL4 2; + , w 1118; + ; GMR-GAL4 3 or w 1118; sev-GAL4; + flies were crossed with w 1118; UAS-GFP; + flies and the w 1118; sev-GAL4/UAS-GFP, w 1118; GMR-GAL4 2 / UAS-GFP or w 1118; UAS-GFP/ + ; GMR-GAL4 3/+ progeny eggs were collected at hourly intervals. Larvae that hatched during a period of 1 h were separated to obtain synchronously growing larvae. Similarly, larvae that began pupation during a period of 1 h were separated to obtain pupae of defined age (expressed as h after pupa formation or h APF). The first, second and late third instar actively moving larvae and 8–9 a and 24–25 h APF pupae were dissected in Poels’ salt solution (PSS, Lakhotia and Tapadia 1998) and internal tissues fixed in 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS, 130 mm NaCl, 7 mm Na2HPO4, 3 mm KH2PO4, pH 7.2) for 20 min. After three 10 min washes in 0.1% PBST (PBS + 0.1% Triton-X-100), the tissues were counterstained with DAPI (4′,6-diamidino-2-phenylindole dihydrochloride, 1 µg/mL) and mounted in DABCO for imaging the GFP expression. To examine the expression of the reporter gene in embryonic stages, embryos of different genotypes were fixed after removing chorion and vitelline membranes, and were immunostained using rabbit antiGFP primary (Sigma Aldrich, St Louis, USA, 1 : 50) and Alexa Flour 488 conjugated antirabbit secondary (Molecular Probes, Eugene, USA, 1 : 200) antibodies as described (Van Vactor and Kopczynski 1999). Chromatin was counterstained with DAPI (1 µg/mL) and the embryos were mounted in DABCO.
Nature and anatomical positions of the GFP expressing cells in the brain and ventral ganglia (central nervous system, CNS) of w 1118; sev-GAL4/UAS-GFP, w 1118; UAS-GFP/ + ; GMR-GAL4 3 / + and w 1118; GMR-GAL4 2 /UAS-GFP larvae were ascertained by immunostaining with mouse antiElav (Developmental Studies Hybridoma Bank (DSHB), 1 : 100), or mouse antiFasciclin II (1D4, DSHB, 1 : 75) primary and antimouse Cy3 (Sigma Aldrich, 1 : 200) secondary antibodies as described earlier (Singh and Lakhotia 2012). The immunostained tissues were counterstained with DAPI (1 µg/mL) and mounted in DABCO for imaging.
To know the nature of CNS neurons expressing UAS-GFP under the sev-GAL4or GMR-GAL4drivers (see Results), dopaminergic (Ddc-GAL4) neuron-specific driver was used to drive the UAS-GFP reporter either alone or in conjunction with sev-GAL4 driver in progeny of w 1118; sev-GAL4 UAS- GFP; + female and w 1118; Ddc-GAL4; + male flies. The GFP expression in CNS of the progeny larvae/pupae was examined as above. To determine if the sev-GAL4 >UAS-GFP expressing neurons in the CNS were cholinergic, late third instar w 1118; sev-GAL4/UAS-GFP larval CNS were immunostained with anticholine acetyltransferase (DSHB, 1 : 100) primary and antimouse Cy3 (Sigma Aldrich, 1 : 200) secondary antibodies.
To know if the sev-GAL4>UAS-GFPexpression is coincident with expression of the resident sev gene, CNS and eye discs of wandering late third instar (w 1118; sev-GAL4/UAS-GFP) larvae were immunostained with goat antiSevenless (dR-15, Santa Cruz, 1 : 50) and antiGoat Cy3 (Jackson Immuno, 1 : 200) antibodies. The tissues were counterstained with DAPI (1 µg/mL), mounted in DABCO and examined under Carl Zeiss 510 Meta laser scanning confocal microscope.
Results
The sev-GAL4or GMR-GAL4driven expression of UAS-GFP reporter transgene in the ommatidial units behind MF in developing late third instar and pupal eye discs is in agreement with the widely known patterns (figure 1, a&b). Both drivers led to GFP expression in the ommatidial units, optic nerve and axonal projections in the optic lobes of larval/pupal brain ganglia (figure 1, c&d). As expected (Bowtell et al. 1991; Freeman 1996), GMR-GAL4driven GFP expression was more extensive than that of the sev-GAL4driver (figure 1). UAS-GFP expression patterns driven in larval or pupal eye discs by GMR-GAL4 2or GMR-GAL3 2 drivers were seen to be identical (not shown).
Expression of sev-GAL4 driver in other tissues
A detailed examination of GFP expression in embryos, and larval and pupal stages revealed that sev-GAL4 drives UAS-GFPexpression in tissues other than eye discs also (see table 1; figures 2–4). The most remarkable expression of sev-GAL4 (figure 2) driver, other than the eye discs, was in CNS. A specific group of segmentally repeated dorsomedially placed bilateral pairs of cells (figure 2, a, c, e, g&i) in the ventral ganglia of all the three larval instars and early pupal stages expressed GFP when driven by sev-GAL4 driver. The GFP-positive cells in ventral ganglia and eye discs expressed Elav as evidenced by immunostaining with Elav-antibody (figure 3a). Since, Elav protein specifically identifies neuronal cells (Robinow and White 1991), the sev-GAL4driven GFP expressing cells in eye discs and CNS are neuronal in nature.
The GFP expression in the segmentally placed dorsomedial pairs of neurons progressively waned by 24 h APF, leaving GFP expression only in the anterior-most pair (figure 2i). In addition to these paired neurons, the sev-GAL4 driver also led to GFP expression in many other cells at the posterior end and in ventrolateral sides of larval and pupal ventral ganglia (figure 2, b, d, f, h&j). The sev-GAL4driver also activated UAS-GFP in a pair of dorsomedially placed neurons in the brain of third instar larvae (figure 2k).
Anatomical location of the dorsomedially placed pairs of GFP expressing neurons in ventral ganglia was ascertained by immunostaining of the sev-GAL4 >GFP expressing pupal CNS with anti-Fasciclin II (Fas II), which delineates the neuromeres (Vomel and Wegener 2008). As shown in figure 3b, the last thoracic (T3) and each of the abdominal (A1–A7) neuromeres carried a dorsomedial pair of GFP-expressing neurons located close to anterior margins of the Fas II tracts. This pattern of location of the GFP-positive neurons in ventral ganglia is strongly reminiscent of the arrangement of RP2 motor neurons in ventral ganglia, which are also reported to disappear by 24 h APF stage (Winbush and Weeks 2011). This possibility of their being same needs to be further examined.
We did not find sev-GAL4driven GFP expression during embryonic stages or in any part of larval/pupal gut, fat body or other imaginal discs. Dopaminergic or cholinergic nature of the characteristically located segmental dorsomedial pairs of neurons in ventral ganglia was ascertained by coexpressing the sev-GAL4 and Ddc-GAL4to drive GFP expression or by immunostaining of the sev-GAL4>UAS-GFPexpressing CNS for cholinergic neurons (figure 4). Coexpression of sev-GAL4 and Ddc-GAL4 to drive UAS-GFP reporter resulted in GFP expression pattern similar to that seen in presence of either only the Ddc-GAL4or only the sev-GAL4 driver (figure 4, a&b). The sev-GAL4>UAS-GFP expressing dorsomedial pairs of neurons in ventral ganglia did not show any immunostaining for cholinergic neurons (figure 4c). Thus, these results indicate that the sev-GAL4 expressing dorsomedial segmental neurons in larval and pupal ventral ganglia are dopaminergic.
Expression domain of sev-GAL4 driver in eye discs and CNS is coincident with that of the endogenous Sev protein
Since the sev-GAL4driver transgene includes a single copy of the sev enhancer–promoter region to guide expression of GAL4 (Bailey 1999), it is commonly believed that the expression domain of sev-GAL4 transgene mimics that of the sev gene itself. Since our studies revealed expression of GAL4 in specific CNS neurons during larval and pupal stages, we checked if the Sev protein is also present in these neurons through immunostaining of eye discs and the CNS of sev-GAL4 >UAS-GFP third instar larvae with Sev antibody (figure 5). As expected (Tomlinson et al. 1987), Sev protein was present at apical surface of the R3, R4, R7 and to a less extent of the R1 and R6 photoreceptor cells of each ommatidial unit so that optical sections of eye discs along the apical plane showed rows of well-arranged circular rings of Sev protein posterior to the morphogenetic furrow (figure 5a). Since the GFP expression in the present UAS-GFP reporter is nuclear, GFP fluorescence in the same photoreceptors was seen in more medial optical sections (figure 5b) which did not show Sev signal. To confirm that the nuclear GFP signal indeed originated from the photoreceptor cells with Sev signal at their apical plane, we examined apico-basal plane optical sections of eye discs (figure 5c) which clearly showed that the Sev and GFP fluorescence signals were emanating from the same photoreceptor cells.
Also in the CNS, the sev-GAL4 >UAS-GFP positive neurons showed stronger staining for Sev protein (figure 5, d&e). Fibrous tracts with stronger Sev staining appeared to be emanating from these neurons, especially in sections from the medial parts of ventral ganglia (figure 5, d&e). As noted above for eye discs, the nuclear GFP and cytoplasmic Sev protein did not appear to be typically colocalized. However, orthogonal views (X–Z or Y–Z planes) of the stacks of confocal optical sections, clearly revealed their common presence in specific neurons and their axonal projections (figure 5, d&e).
Besides the eye discs, GMR-GAL4 drives UAS-GFP expression in several other tissues, including the sev-GAL4 expressing CNS neurons
As in the case of sev-GAL4, we examined the expression domains of the two GMR-GAL4 drivers through the UAS- GFP reporter. It was seen that besides the earlier noted expression in eye discs and optic lobes (figure 1), both the GMR- GAL4 drivers led to GFP expression in CNS in a pattern similar to that of sev-GAL4 driver (compare figures 2 and 6; see table 1). To know if the sev-GAL4-driven GFP expressing neuronal cells in CNS are same as those seen with the GMR- GAL4 driver, we generated w 1118; sev-GAL4 UAS-GFP/ GMR-GAL4 2 progeny through appropriate genetic crosses so that the UAS-GFP transgene was simultaneously driven by both the GAL4 drivers. It was seen that the pattern of GFP expression in the ventral ganglia in these larvae and pupae remained similar (not shown) to that when the UAS-GFP transgene was driven by any one of the drivers. This indicates that sev-GAL4 and GMR-GAL4 drivers activate UAS-GFP in a common set of neuronal cells in ventral ganglia.
In addition, two GMR-GAL4 drivers also expressed in a common or in transgene insertion-specific manner, in several other embryonic, larval and pupal tissues (table 1; figure 7). Both the GMR-GAL4drivers activated GFP expression in embryonic eye primordia (figure 7, a&b), the eye discs in 1st and 2nd instar larvae (figure 7, c, f, i&j), Bolwig’s organ with its nerve (embryonic and later stages) and in neuronal precursors of ocelli present in between the two optic lobes (figure 7, k, l, m & n). The GMR-GAL4 driven UAS-GFP expression in Bolwig’s organ and ocelli is expected since the GMR-GAL4 (Freeman 1996) construct contains a pentamer of truncated glass-binding sites derived from the Drosophila Rh1 promoter (Hay et al. 1994) and glass protein is known to be expressed in these tissues (Moses et al. 1989; Moses and Rubin 1991). A few other unidentified embryonic cells also showed varying degree of GMR-GAL4 >UAS-GFP expression (figure 7, a&b).
Interestingly, we noted certain differences between the two GMR-GAL4 insertion lines in their activation of the UAS-GFP transgene. While the GMR-GAL4 2 line showed strong GFP expression in third instar larval spiracular glands (figure 7i), the GMR-GAL4 3 (figure 7j) did not activate UAS-GFP in this tissue. On the other hand, the GFP expression in larval tracheae was much more extensive and stronger with GMR-GAL4 3 than with GMR-GAL4 2 driver (figure 7, i&j). Another significant difference between the two GMR-GAL4 drivers was in the expression of the brain lobes (figure 7, g&h). While in case of GMR-GAL4 2, only one single pair of neuron in middorsal part showed presence of GFP (figure 7g), large number of neuronal cells and the mushroom body were also distinctly GFP-positive in the GMR-GAL4 3 (figure 7h). Further, GFP expression was seen in embryonic (figure 7b) and early larval stage salivary glands (figure 7p) but not in third instar larvae (not shown) in the case of GMR-GAL4 3; the GMR-GAL4 2 line did not show GFP expression in embryonic or larval salivary glands at any stage (figure 7o).
Discussion
The sev-GAL4 and GMR-GAL4 drivers are very extensively used by fly researchers to target expression of the UAS-responder transgene to the differentiating eyes. However, our observations clearly show that each of these drivers leads to expression of the reporter gene in several additional tissues, including regions of the CNS. Our study further reveals that the expression domains of the endogenous sev gene and the sev-GAL4 transgene are comparable in eye discs as well as the CNS since the endogenous Sevenless protein was present in all cells that expressed sev-GAL4 driven UAS-GFP transgene. It remains to be seen if the endogenous glass gene also expresses in cells expressing GFP under the GMR-GAL4 driver. It is interesting that the sev-GAL4 and GMR-GAL4 drivers share their expression not only in eye discs but also in a common set of neurons in ventral ganglia. This suggests some shared developmental roles of the two genes in these neuronal cells. However, unlike the sev-GAL4 driver, the GMR-GAL4 driver is active in several nonneuronal tissues as well.
Recently, Li et al. (2012) also reported that the GMR-GAL4 driver causes the lacZ reporter gene to express in wing and leg discs, trachea, etc., besides the eye discs. They did not report expression of the GMR-GAL4 driver in the CNS. However, unlike their report, we did not find GFP expression in wing or leg discs with either of the two GMR-GAL4 drivers used by us. Several possible factors may explain the differences between Li et al. (2012) and our results. Firstly, the X-Gal-based lacZ reporter assay used by Li et al. (2012) is much less sensitive than the GFP-fluorescence assay. The endogenously present fly ß-galactosidase can also generate erroneous signals if not properly controlled (Schnetzer and Tyler 1996). The lacZ assay (Li et al. 2012) may have failed to detect the weak GFP fluorescence in the neuronal cells of ventral ganglia observed in our study. Finally, our present results with the two GMR-GAL4 insertion lines reveal that it is possible that different GMR-GAL4 driver lines may have subtle differences in their expression domains owing to small differences in the transgene construct and/or differences in their site of insertion. Site of insertion of transgene can indeed have positional effects, especially if boundary elements are not placed around the transgene (Labrador and Corces 2002; Srinivasan and Mishra 2012).
Power of the GAL4-UAS binary system of targeted gene expression (Brand and Perrimon 1993) lies in the precision of target gene’s ectopic expression. However, in the absence of detailed information about the specific expression domain/s of a given GAL4 driver construct, interpretations about functions of a gene or its interaction/s with other gene/s may become misleading. The present results, besides providing detailed information on the expression domains of the commonly used sev-GAL4 and GMR-GAL4 drivers, emphasize the need for a careful confirmation of expression domains of the GAL4 driver being used in a given study, rather than relying only on the empirically claimed expression domains.
References
Bailey A. 1999 sevenless-GAL4 transgene (http://flybase.org/reports/FBrf0125052.html).
Bowtell D. D. L., Thomson L. M. M., Hackett D. and Rubin G. M. 1991 Analysis of the enhancer element that controls expression of sevenless in the developing Drosophila eye. Proc. Natl. Acad. Sci. USA 88, 6853–6857.
Brand A. H. and Perrimon N. 1993 Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401–415.
Firth L. C., Li W., Zhang H. and Baker N. E. 2006 Analyses of RAS regulation of eye development in Drosophila melanogaster. Methods Enzymol. 407, 711–721.
Freeman M. 1996 Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell 87, 651–660.
Hay B. A., Wolff T. and Rubin G. M. 1994 Expression of baculovirus P35 prevents cell death in Drosophila. Development 120, 2121–2129.
Igaki T., Kanda H., Yamamoto-Goto Y., Kanuka H., Kuranaga E., Aigaki T. et al. 2002 Eiger, a TNF superfamily ligand that triggers the Drosophila JNK pathway. EMBO J. 21, 3009–3018.
Labrador M. and Corces V. G. 2002 Setting the boundaries of chromatin domains and nuclear organization. Cell 111, 151–154.
Lakhotia S. C. and Tapadia M. G. 1998 Genetic mapping of the amide response element(s) of the hsrw locus of Drosophila melanogaster. Chromosoma 107, 127–135.
Li W. Z., Li S. L., Zheng Y. L., Zhang S. P. and Xue L. 2012 A broad expression profile of the GMR-GAL4 driver in Drosophila melanogaster. Genet. Mol. Res. 11, 1997–2002.
Mallik M. and Lakhotia S. C. 2009a RNAi for the large non-coding hsrw transcripts suppresses polyglutamine pathogenesis in Drosophila models. RNA Biol. 6, 464–478.
Mallik M. and Lakhotia S. C. 2009b The developmentally active and stress-inducible noncoding hsrw gene is a novel regulator of apoptosis in Drosophila. Genetics 183, 831–852.
Maxiner A., Hecker T. P., Phan Q. N. and Wassarman D. A. 1998 A screen for mutations that prevent lethality caused by expression of activated sevenless and Ras1 in the Drosophila embryo. Dev. Genet. 23, 347–361.
Morris E. J., Michaud W. A., Ji J. Y., Moon N. S., Rocco J. W. and Dyson N. J. 2006 Functional identification of api5 as a suppressor of e2f-dependent apoptosis in vivo. PLoS Genet. 11, e196.
Moses K. and Rubin G. M. 1991 Glass encodes a site-specific DNA-binding protein that is regulated in response to positional signals in the developing Drosophila eye. Genes Dev. 5, 583–593.
Moses K., Ellis M. C. and Rubin G. M. 1989 The glass gene encodes a zinc-finger protein required by Drosophila photoreceptor cells. Nature 340, 531–536.
Robinow S. and White K. 1991 Characterization and spatial distribution of the ELAV protein during Drosophila melanogaster development. J. Neurobiol. 22, 443–461.
Sang T. K. and Jackson G. R. 2005 Drosophila models of neurodegenerative disease. NeuroRx 2, 438–446.
Schnetzer J. W. and Tyler M. S. 1996 Endogenous beta-galactosidase activity in the larval, pupal, and adult stages of the fruit fly, Drosophila melanogaster, indicates need for caution in lacZ fusion-gene studies. Biol. Bull. 190, 173–187.
Singh A. K. and Lakhotia S. C. 2012 The hnRNP A1 homolog Hrp36 is essential for normal development, female fecundity, omega speckle formation and stress tolerance in Drosophila melanogaster. J. Biosci. 37, 659–678.
Srinivasan A. and Mishra R. K. 2012 Chromatin domain boundary element search tool for Drosophila. Nucleic Acids Res. 40, 4385–4395.
Tomlinson A., Bowtell D. D., Hafen E. and Rubin G. M. 1987 Localization of the sevenless protein, a putative receptor for positional information, in the eye imaginal disc of Drosophila. Cell 51, 143–150.
Van Vactor D. and Kopczynski C. 1999 Anatomical techniques for analysis of nervous system development in the Drosophila embryo. In A comparative methods approach to the study of oocytes and embryos (ed. J. Richter), pp. 490–513. Oxford University Press, New York, USA.
Vomel M. and Wegener C. 2008 Neuroarchitecture of aminergic systems in the larval ventral ganglion of Drosophila melanogaster. PLoS One 3, e1848.
Winbush A. and Weeks J. C. 2011 Steroid-triggered, cell-autonomous death of a Drosophila motoneuron during metamorphosis. Neural Dev. 6, 15.
Acknowledgements
We thank the Bloomington Stock Center (USA) for providing some of the fly stocks used in this study. We thank the Department of Science and Technology, Govt. of India New Delhi and the Banaras Hindu University for the Confocal Microscopy facility. MR is supported through Research Fellowship from the CSIR.
Author information
Authors and Affiliations
Corresponding author
Additional information
[Ray M. and Lakhotia S. C. 2015 The commonly used eye-specific sev-GAL4 and GMR-GAL4 drivers in Drosophila melanogaster are expressed in tissues other than eyes also. J. Genet. 94, xx–xx]
Rights and permissions
About this article
Cite this article
RAY, M., LAKHOTIA, S.C. The commonly used eye-specific sev-GAL4 and GMR-GAL4 drivers in Drosophila melanogaster are expressed in tissues other than eyes also. J Genet 94, 407–416 (2015). https://doi.org/10.1007/s12041-015-0535-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-015-0535-8